We then investigated whether FASN could regulate the adaptive and constitutive expression of the immune checkpoint PD-L1 in cancer cells, including FASN-driven PD-L1 palmitoylation, a critical post-translational modification required for the structural integrity and functionality of cell membrane-bound PD-L1 [21, 22]. Here, FASN is linked to cancer.